| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.0073 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.0071 | 1 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.0059 | 1 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.006 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00093 | 1 |